In-vitro Inflammatory Bowel Disease Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

In-vitro Inflammatory Bowel Disease Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

  • Transparency Market Research
  • July 2020
  • Pharmaceutical
  • 164 pages

Report Description

1
1

In-vitro Inflammatory Bowel Disease Diagnostic Market – Scope of the Report

TMR’s report on the global in-vitro inflammatory bowel disease diagnostic market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global in-vitro inflammatory bowel disease diagnostic market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in-vitro inflammatory bowel disease diagnostic market from 2020 to 2030.

The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global in-vitro inflammatory bowel disease diagnostic market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global in-vitro inflammatory bowel disease diagnostic market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global in-vitro inflammatory bowel disease diagnostic market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in-vitro inflammatory bowel disease diagnostic market.

The report also delves into the competition landscape of the global in-vitro inflammatory bowel disease diagnostic market. Key players operating in the global in-vitro inflammatory bowel disease diagnostic market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global in-vitro inflammatory bowel disease diagnostic market that have been profiled in this report.

Key Questions Answered in In-vitro Inflammatory Bowel Disease Diagnostic Market Report

  • What is the sales/revenue generated by in-vitro inflammatory bowel disease diagnostic products across all regions during the forecast period?
  • What are the opportunities in the global in-vitro inflammatory bowel disease diagnostic market?
  • What are the major drivers, restraints, opportunities, and threats in the global market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which product segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

In-vitro Inflammatory Bowel Disease Diagnostic Market – Research Objectives and Research Approach

The comprehensive report on the global in-vitro inflammatory bowel disease diagnostic market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global in-vitro inflammatory bowel disease diagnostic market in terms of product, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global in-vitro inflammatory bowel disease diagnostic market.

Have query on this report?

Make an Enquiry

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global In-vitro Inflammatory Bowel Disease Diagnostic Market 

4. Market Overview
4.1. Introduction & Overview
4.2. Product Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities 
4.4. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast, 2018–2030

5. Market Outlook 
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Key Industry Developments
5.3. Fecal Biomarkers – Advancement 

6. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030
6.2.1. Assays/Biomarker
6.2.1.1. Calprotectin
6.2.1.2. Lactoferrin
6.2.1.3. Bile Acids
6.2.1.4. H. pylori SA
6.2.1.5. Pancreatic Elastase
6.2.1.6. Others
6.2.2. Analyzers
6.3. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis, by Product

7. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$) Forecast, by End-user, 2018–2030
7.2.1. Diagnostic Laboratories
7.2.2. Hospitals
7.2.3. Research Institutes
7.3. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis, by End-user

8. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis, by Region

9. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast
9.1. Introduction
9.2. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030
9.2.1. Assays/Biomarker
9.2.1.1. Calprotectin
9.2.1.2. Lactoferrin
9.2.1.3. Bile Acids
9.2.1.4. H. pylori SA
9.2.1.5. Pancreatic Elastase
9.2.1.6. Others
9.2.2. Analyzers
9.3. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030
9.3.1. Diagnostic Laboratories
9.3.2. Hospitals
9.3.3. Research Institutes
9.4. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country, 2018–2030
9.4.1. U.S.
9.4.2. Canada
9.5. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country 

10. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast
10.1. Introduction
10.2. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030
10.2.1. Assays/Biomarker
10.2.1.1. Calprotectin
10.2.1.2. Lactoferrin
10.2.1.3. Bile Acids
10.2.1.4. H. pylori SA
10.2.1.5. Pancreatic Elastase
10.2.1.6. Others
10.2.2. Analyzers
10.3. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030
10.3.1. Diagnostic Laboratories
10.3.2. Hospitals
10.3.3. Research Institutes
10.4. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region

11. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast
11.1. Introduction
11.2. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030
11.2.1. Assays/Biomarker
11.2.1.1. Calprotectin
11.2.1.2. Lactoferrin
11.2.1.3. Bile Acids
11.2.1.4. H. pylori SA
11.2.1.5. Pancreatic Elastase
11.2.1.6. Others
11.2.2. Analyzers
11.3. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030
11.3.1. Diagnostic Laboratories
11.3.2. Hospitals
11.3.3. Research Institutes
11.4. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region

12. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast
12.1. Introduction
12.2. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030
12.2.1. Assays/Biomarker
12.2.1.1. Calprotectin
12.2.1.2. Lactoferrin
12.2.1.3. Bile Acids
12.2.1.4. H. pylori SA
12.2.1.5. Pancreatic Elastase
12.2.1.6. Others
12.2.2. Analyzers
12.3. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030
12.3.1. Diagnostic Laboratories
12.3.2. Hospitals
12.3.3. Research Institutes
12.4. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region

13. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast
13.1. Introduction
13.2. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030
13.2.1. Assays/Biomarker
13.2.1.1. Calprotectin
13.2.1.2. Lactoferrin
13.2.1.3. Bile Acids
13.2.1.4. H. pylori SA
13.2.1.5. Pancreatic Elastase
13.2.1.6. Others
13.2.2. Analyzers
13.3. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030
13.3.1. Diagnostic Laboratories
13.3.2. Hospitals
13.3.3. Research Institutes
13.4. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region

14. Competition Landscape
14.1. Market Position Analysis, by Company, 2019
14.2. Company Profiles
14.2.1. DiaSorin S.p.A
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Company Financials
14.2.1.3. Growth Strategies
14.2.1.4. SWOT Analysis
14.2.2. F. Hoffmann-La Roche Ltd 
14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.2.2. Company Financials
14.2.2.3. Growth Strategies
14.2.2.4. SWOT Analysis
14.2.3. Siemens Healthineers AG 
14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.3.2. Company Financials
14.2.3.3. Growth Strategies
14.2.3.4. SWOT Analysis
14.2.4. Abbott 
14.2.4.1. Company Overview (HQ, Business Segments)
14.2.4.2. Company Financials
14.2.4.3. Growth Strategies
14.2.4.4. SWOT Analysis
14.2.5. Quidel Corporation
14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.5.2. Company Financials
14.2.5.3. Growth Strategies
14.2.5.4. SWOT Analysis
14.2.6. BÜHLMANN Laboratories AG
14.2.6.1. Company Overview (HQ, Business Segments)
14.2.6.2. Growth Strategies
14.2.6.3. SWOT Analysis
14.2.7. American Laboratory Products Company (ALPCO) 
14.2.7.1. Company Overview (HQ, Business Segments)
14.2.7.2. Growth Strategies
14.2.7.3. SWOT Analysis
14.2.8. Certest Biotec SL
14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.8.2. Growth Strategies
14.2.8.3. SWOT Analysis
14.2.9. Biosystems S.A. 
14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.9.2. Growth Strategies
14.2.9.3. SWOT Analysis

List of Tables

Table 01: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 02: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarkers, 2018–2030
Table 03: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 04: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 05: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 06: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 07: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarker, 2018–2030
Table 08: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 09: Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 10: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 11: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarkers, 2018–2030
Table 12: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 13: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 14: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 15: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarkers, 2018–2030
Table 16: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 17: Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 18: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 19: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarkers, 2018–2030
Table 20: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 21: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 22: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 23: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarker, 2018–2030
Table 24: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074